PDCD1 and myeloid sarcoma: Likewise, MS patients were shown to have dramatically higher PD-1 expression in CD4+CD25bright FoxP3-exon2+ Treg cells compared to healthy controls, contributing to the dysfunction and exhaustion of these cells [20].